2025 annual financial data
20/20 Biolabs 2025 Operating margin
20/20 Biolabs 2025 operating margin with verified reported values.
Direct answer
Operating margin was -162.87%.
Operating income was -3,330,871 USD and net income was -3,738,821 USD.
Operating cash flow was -1,919,720,000 USD.
Get free 20/20 Biolabs email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,045,133 USD
- Operating income
- -3,330,871 USD
- Net income
- -3,738,821 USD
- Operating cash flow
- -1,919,720,000 USD